Befejeződött1. fázis
Phase Ib Randomised, Placebo-controlled, Double-blind, Multicentre Study to Assess the Effects and Safety of AZD5462 on top of Dapagliflozin in Participants with Heart Failure and Moderate Renal Impairment
Key facts
- Where
- Sofia, BulgáriaSee the site
- Phase
- 1. fázis
Where in Bulgária
- Medical Center Comac Medical Ltd.Sofia, BulgáriaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- AstraZeneca AB
- Trial code
- EU 2024-513142-11-00
- Record updated
- 2025. április 9.